Sun Pharma's investors face a risk from India's unbranded ge

Its large presence in India's branded generic drug market exposes it the most to a risk from trade generics. But other major pharma companies are at risk too

Related Keywords

India , Jan Aushadhi , Sun Pharma , , Generic Drugs , India Pharma Market , Trade Generics , Branded Medicines , Business Growth , Volumes , Stocks ,